The IRS recently stopped processing Employee Retention Tax Credit (ERTC) claims. The ERTC was introduced during COVID as a pandemic-related tax credit that offered money to help employers that retained their employees during the pandemic.
Read More
Independence knows that COVID-19 vaccines are important tools that help reduce the risk of disease, hospitalization, and death, and for that reason, they cover COVID-19 vaccines and boosters at no cost from in-network providers or pharmacies.
Read More
On March 17, 2022, the New York State Department of Health (DOH) ended the designation of COVID-19 as an airborne infectious disease that presents a serious risk of harm to public health under the Health and Essential Rights Act (NY HERO Act).
Read More
On Jan. 25, 2022, OSHA provided notice that it is withdrawing its COVID-19 vaccination and weekly testing emergency temporary standard (ETS). Read to view how this impacts state plans and employers.
Read More
The new FAQs specifically address the definition of “disability” and how to determine whether an individual with COVID-19 meets it under the Americans with Disabilities Act (ADA).
On Sept. 9, 2021, President Biden announced that the Occupational Safety and Health Administration (OSHA) is developing an emergency temporary standard (ETS).
Read More
On Monday, Aug. 23, 2021, the Food and Drug Administration (FDA) gave full approval to the Pfizer-BioNTech coronavirus vaccine. It is the first full approval of any coronavirus vaccine in the United States. The other vaccines, Moderna and Johnson & Johnson, are still available under emergency use authorization (EUA) granted by the FDA. The Moderna vaccine is currently under review for full approval, and the Johnson & Johnson vaccine is expected to begin the process soon.
Read More